Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A trial assessing Coronavirus vaccine

Trial Profile

A trial assessing Coronavirus vaccine

Status: Planning
Phase of Trial: Phase I

Latest Information Update: 20 Mar 2020

At a glance

  • Drugs Coronavirus vaccine (Primary)
  • Indications COVID 2019 infections
  • Focus Therapeutic Use
  • Most Recent Events

    • 20 Mar 2020 New trial record
    • 18 Mar 2020 According to a Geovax media release, this trial is expected to start before the end of this year.

Trial Overview

Purpose

This trial will be assessing the coronavirus vaccine.

Diseases Treated

Indication Qualifiers Patient Segments
COVID 2019 infections treatment -

Subjects

  • Subject Type patients
  • Sex male & female
  • Age Group adult

Trial Details

Organisations

  • Affiliations GeoVax Labs

Trial Dates

Other Details

  • Design prospective
  • Phase of Trial Phase I
  • Location Unknown
  • Focus Therapeutic Use

Interventions

Drugs Route Formulation
Coronavirus vaccinePrimary Drug
-
-

Coronavirus-vaccine

Trial History

Event Date Event Type Comment
20 Mar 2020 New trial record New trial record Updated 20 Mar 2020
18 Mar 2020 Other trial event According to a Geovax media release, this trial is expected to start before the end of this year. Updated 20 Mar 2020

References

  1. GeoVax Labs. GeoVax Progresses in Coronavirus (COVID-19) Vaccine Development Program. Media-Rel 2020;.

    Media Release
Back to top